8 citations · 21 across the 6 of their papers we have counts for
3 papers · 1 filter
HIV, TB and ART: the CD4 enigma
Brian Williams, Eleanor Gouws
The concentration of CD4 T-lymphocytes (CD4 count), in a person's plasma is widely used to decide when to start HIV-positive people on anti-retroviral therapy (ART) and to predict…
Pre-exposure prophylaxis (PrEP) versus treatment-as-prevention (TasP) for the control of HIV: Where does the balance lie?
Brian G. Williams, Eleanor Gouws, John Hargrove +2
Anti-retroviral drugs can reduce the infectiousness of people living with HIV by about 96%--treatment as prevention or TasP--and can reduce the risk of being infected by an HIV pos…
Anti-retroviral therapy for HIV: who should we test and who should we treat?
Brian G. Williams, Renier van Rooyen, Martin Nieuwoudt
In most countries CD4+ cell counts are still used for deciding when to start HIV-positive people on anti-retroviral therapy. However, various CD4+ thresholds, 200, 350 or 500/\muL,…